A gain-of-function variation in PLCG1 causes a new immune dysregulation diseasePanfeng Tao(Zhejiang University), Qing Zhou(Zhejiang University)Journal of Allergy and Clinical ImmunologyJuly 6, 202310.1016/j.jaci.2023.06.020Cited by 34SaveCiteExport RISWatch citationsRelated PapersIdentification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design|Immunity|2023|77RIPK1 Biallelic Activating Variants lead to Autoinflammatory Disease Driven by T cell Death|medRxiv|2024|3